Erin Pennock Foff, Chief Medical Officer at MapLight Therapeutics, Inc. (MPLT), sold 47,158 shares at $36.16 ($1.7M) on 2026-07-15, disclosed to the SEC on 2026-07-17.
Scheduled sale ($1.7M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.00 | 4,465 | $161K | 9.3% |
| 2 | $36.16 | 7,155 | $259K | 14.9% |
| 3 | $36.99 | 8,972 | $332K | 19.1% |
| 4 | $37.04 | 7,845 | $291K | 16.8% |
| 5 | $37.54 | 18 | $676 | 0.0% |
| 6 | $36.46 | 9,163 |
| $334K |
| 19.3% |
| 7 | $37.26 | 5,865 | $219K | 12.6% |
| 8 | $37.96 | 19 | $721 | 0.0% |
| 9 | $37.90 | 3,656 | $139K | 8.0% |
| Total | $36.78 avg | 47,158 | $1.7M | 100% |
| Filing → |
| MPLT | SELL | 2026-05-06 | $1.4M | — | Filing → |
| MPLT | SELL | 2026-04-17 | $87K | — | Filing → |